Dual listings always sound like a good idea -access to new capital etc - but in practise they often just impose additional admin burden and costs on companies who later regret it, and they are messy to undo.
- Forums
- ASX - By Stock
- GMV
- News: GMV G Medical Innovations Holdings Files For U.S. Listing Of Up To $17.3 Million
News: GMV G Medical Innovations Holdings Files For U.S. Listing Of Up To $17.3 Million, page-179
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online